Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
DoD Kidney Cancer, Academy of Kidney Cancer Investigators - Dean Leadership Award
The KCRP Academy of Kidney Cancer Investigators Award mechanisms, which are being offered for the first time in FY19, support a unique, interactive virtual academy providing intensive mentoring, national networking, collaborations, and a peer group for junior faculty.
The overarching goal of
the Academy of Kidney Cancer Investigators (AKCI) is to develop successful, highly productive kidney cancer researchers in a collaborative research and career development environment.
The AKCI is a virtual career development and research training platform that will consist of four Early-Career Investigator (ECI)/Designated Mentor pairs from different institutions, and one Academy Dean.
The Academy Dean’s role will be to assure the growth and professional development of the ECIs in collaboration with their Designated Mentors, and facilitate communication and collaboration among all of the Academy members.
The Academy Dean must be an independent, established kidney cancer researcher, as evidenced by cancer research funding, publication record, and significant accomplishments within the field of cancer.
The Academy Dean must demonstrate a strong record of mentoring and training junior investigators, a commitment to leadership, and the ability to objectively assess the research progress of all of the ECIs in the AKCI.
Responsibilities of the Academy Dean include, but are not limited to, the following:
• Act as a resource for all ECIs and Designated Mentors in the Academy over the 5-year period of performance.
• Facilitate communication and collaboration among all of the ECIs and Designated Mentors (including periodic interactive communication among all Academy members).
• Develop assessment criteria to evaluate the research progress made by all of the ECIs, as well as their career progression and sustainment as independent investigators in kidney cancer research.
• Provide constructive critiques with the goal of advancing the research and professional careers of the ECIs and strengthening the mentorship of the Designated Mentors.
• Provide avenues to increase the visibility of ECIs within the kidney cancer research and advocacy communities (e.g., peer review, conferences, editorial boards).
• Support the professional development, to include laboratory management skills, of the ECIs into leading researchers through invited presentations by experts outside of the AKCI.
• Plan and host a biennial multi-day workshop for all ECI/Designated Mentor pairs to present their research, share knowledge, develop mentoring skills, and develop collaborative efforts within the Academy.
− In alternate years, plan and host a 1-day KCRP AKCI workshop.
• Assemble an Advisory Board to the Dean of the Academy, at the discretion of the Dean.
The anticipated direct costs budgeted for the entire period of performance for an FY19 KCRP AKCIDA will not exceed $625,00 0. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.
Note:
An invited oral presentation is a requirement for application review of the KCRP AKCIDA, as described in Section II.D.
2. b, Full Application Submission Content.
The CDMRP expects to allot approximately $ 1. 0M to fund approximately one Academy of Kidney Cancer Investigators – Dean Leadership Award application.
Funding of applications received is contingent upon the availability of Federal funds for this program as well as the number of applications received, the quality and merit of the applications as evaluated by scientific and programmatic review, and the requirements of the Government.
Funds to be obligated on any award resulting from this funding opportunity will be available for use for a limited time period based on the fiscal year of the funds.
It is anticipated that awards made from this FY19 funding opportunity will be funded with FY19 and FY20 funds, which will expire for use on September 30, 2025, and September 30, 2026, respectively.
Awards will be made no later than September 30, 202 0. For additional information refer to Section II.F.1, Federal Award Notices.
The types of awards made under the Program Announcement will be assistance agreements (grants or cooperative agreements).
The level of involvement on the part of the Department of Defense (DoD) during project performance is the key factor in determining whether to award a grant or cooperative agreement.
An assistance agreement (grant or cooperative agreement) is appropriate when the Federal Government transfers a “thing of value” to a “state, local government,” or “other recipient” to carry out a public purpose of support or stimulation authorized by a law of the United States, instead of acquiring property or service for the direct benefit and use of the U. S. Government.
An assistance agreement can take the form of a grant or cooperative agreement.
If “no substantial involvement” on the part of the funding agency is anticipated, a grant award will be made (31 USC 6304).
Conversely, if substantial involvement on the part of the funding agency is anticipated, a cooperative agreement will be made (31 USC 6305) and the award will identify the specific substantial involvement.
Substantial involvement may include collaboration, participation, or intervention in the research to be performed under the award.
The award type, along with the start date, will be determined during the negotiation process.
The overarching goal of
the Academy of Kidney Cancer Investigators (AKCI) is to develop successful, highly productive kidney cancer researchers in a collaborative research and career development environment.
The AKCI is a virtual career development and research training platform that will consist of four Early-Career Investigator (ECI)/Designated Mentor pairs from different institutions, and one Academy Dean.
The Academy Dean’s role will be to assure the growth and professional development of the ECIs in collaboration with their Designated Mentors, and facilitate communication and collaboration among all of the Academy members.
The Academy Dean must be an independent, established kidney cancer researcher, as evidenced by cancer research funding, publication record, and significant accomplishments within the field of cancer.
The Academy Dean must demonstrate a strong record of mentoring and training junior investigators, a commitment to leadership, and the ability to objectively assess the research progress of all of the ECIs in the AKCI.
Responsibilities of the Academy Dean include, but are not limited to, the following:
• Act as a resource for all ECIs and Designated Mentors in the Academy over the 5-year period of performance.
• Facilitate communication and collaboration among all of the ECIs and Designated Mentors (including periodic interactive communication among all Academy members).
• Develop assessment criteria to evaluate the research progress made by all of the ECIs, as well as their career progression and sustainment as independent investigators in kidney cancer research.
• Provide constructive critiques with the goal of advancing the research and professional careers of the ECIs and strengthening the mentorship of the Designated Mentors.
• Provide avenues to increase the visibility of ECIs within the kidney cancer research and advocacy communities (e.g., peer review, conferences, editorial boards).
• Support the professional development, to include laboratory management skills, of the ECIs into leading researchers through invited presentations by experts outside of the AKCI.
• Plan and host a biennial multi-day workshop for all ECI/Designated Mentor pairs to present their research, share knowledge, develop mentoring skills, and develop collaborative efforts within the Academy.
− In alternate years, plan and host a 1-day KCRP AKCI workshop.
• Assemble an Advisory Board to the Dean of the Academy, at the discretion of the Dean.
The anticipated direct costs budgeted for the entire period of performance for an FY19 KCRP AKCIDA will not exceed $625,00 0. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.
Note:
An invited oral presentation is a requirement for application review of the KCRP AKCIDA, as described in Section II.D.
2. b, Full Application Submission Content.
The CDMRP expects to allot approximately $ 1. 0M to fund approximately one Academy of Kidney Cancer Investigators – Dean Leadership Award application.
Funding of applications received is contingent upon the availability of Federal funds for this program as well as the number of applications received, the quality and merit of the applications as evaluated by scientific and programmatic review, and the requirements of the Government.
Funds to be obligated on any award resulting from this funding opportunity will be available for use for a limited time period based on the fiscal year of the funds.
It is anticipated that awards made from this FY19 funding opportunity will be funded with FY19 and FY20 funds, which will expire for use on September 30, 2025, and September 30, 2026, respectively.
Awards will be made no later than September 30, 202 0. For additional information refer to Section II.F.1, Federal Award Notices.
The types of awards made under the Program Announcement will be assistance agreements (grants or cooperative agreements).
The level of involvement on the part of the Department of Defense (DoD) during project performance is the key factor in determining whether to award a grant or cooperative agreement.
An assistance agreement (grant or cooperative agreement) is appropriate when the Federal Government transfers a “thing of value” to a “state, local government,” or “other recipient” to carry out a public purpose of support or stimulation authorized by a law of the United States, instead of acquiring property or service for the direct benefit and use of the U. S. Government.
An assistance agreement can take the form of a grant or cooperative agreement.
If “no substantial involvement” on the part of the funding agency is anticipated, a grant award will be made (31 USC 6304).
Conversely, if substantial involvement on the part of the funding agency is anticipated, a cooperative agreement will be made (31 USC 6305) and the award will identify the specific substantial involvement.
Substantial involvement may include collaboration, participation, or intervention in the research to be performed under the award.
The award type, along with the start date, will be determined during the negotiation process.
Who's Eligible
Relevant Nonprofit Program Categories
Obtain Full Opportunity Text:
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-12-013.html
Additional Information of Eligibility:
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U. S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Full Opportunity Web Address:
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-12-013.html
Contact:
Agency Email Description:
CDMRP Help Desk
Agency Email:
Date Posted:
2019-06-18
Application Due Date:
Archive Date:
2019-10-31
Social Entrepreneurship
Spotlight
Why People Buy from Social Enterprises?
The Guardian has compiled a list of responses to its latest open thread, and has announced the winner of the social enterprise gift hamper packed with presents.
Learn How to Identify and Avoid Grant Scams
